21 results on '"Eisen, Tim"'
Search Results
2. Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma
3. Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study
4. Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinoma
5. Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study
6. IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
7. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
8. The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data
9. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
10. Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
11. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis
12. Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer
13. Ensuring the right PET scan for the right patient
14. Current Status of Targeted Therapy in Metastatic Renal Cell Carcinoma
15. Adjuvant Therapy in Renal Cell Carcinoma: Where Are We?
16. Lack of evidence that p53 Arg72Pro influences lung cancer prognosis: An analysis of survival in 619 female patients
17. Adjuvant Therapy of Renal Cell Carcinoma
18. The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer
19. The biological treatment of renal-cell carcinoma and melanoma
20. The involvement of p38 mitogen-activated protein kinase in the α-melanocyte stimulating hormone (α-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells
21. Cancer biology for the clinic and the lab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.